Video

Pediatric hypertension linked to troubling MRI changes


 

REPORTING FROM JOINT HYPERTENSION 2018

– There’s another reason to worry about hypertension in children: cognitive decline later in life.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

In a pilot study, Marc Lande, MD, a professor of pediatric nephrology at the University of Rochester (N.Y.), and his colleagues found evidence of impaired white matter integrity on MRI in a handful of hypertensive children, similar to what’s found in adults with cognitive impairment from hypertension.

The work is ongoing, but it helps explain the subtle deficits on cognitive testing that have been previously demonstrated in children with hypertension.

“The fact that we are finding anything at this very early stage of disease is striking and somewhat bothersome. The hope is that, by improving blood pressure in children, you can improve subsequent cognition and maybe even delay the onset of dementia further down the road,” Dr. Lande said.

For now, the findings underscore the need to diagnose and manage hypertension in children, but there might be additional treatment implications in the future, especially if blood pressure targets are found that ameliorate the problem.

Dr. Lande explained the issues and the emerging evidence in a video interview at the joint scientific sessions of the American Heart Association Council on Hypertension, AHA Council on Kidney in Cardiovascular Disease, and American Society of Hypertension.

Recommended Reading

New hypertension guidelines would add 15.6 million new diagnoses
MDedge Internal Medicine
DOACs found safer than warfarin in the real world
MDedge Internal Medicine
Valsartan recalls: FDA, manufacturers issue advisories
MDedge Internal Medicine
Diabetes, hypertension, smoking may raise risk for late-onset epilepsy
MDedge Internal Medicine
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Internal Medicine
Blood pressure meds cut cognitive impairment risk
MDedge Internal Medicine
Blood pressure control prevents cognitive impairment
MDedge Internal Medicine
FOURIER analysis: PCSK9 inhibition helps MetS patients the most
MDedge Internal Medicine
Children born from ART at increased risk of developing arterial hypertension
MDedge Internal Medicine
Years after ALLHAT, alpha-blocker use still common, risky
MDedge Internal Medicine